Multidisciplinary Update in Breast Disease 2022 - LIVESTREAM
Course Directors: Pooja P. Advani, M.B.B.S., M.D., Patricia A. Cronin, M.D., Sandhya Pruthi, M.D.
November 3 - 5, 2022 - LIVESTREAM - MST
This two-and-a-half-day continuing medical education course provides a multidisciplinary update in prevention, evaluation, diagnosis, management, and treatment of benign and malignant breast diseases, and high risk and survivorship issues. The course has multidisciplinary experts in their field presenting the latest, diagnostic, treatment and management options. Highlights include, genetics and high-risk management, breast imaging modalities, supplemental screening options for dense breasts, and more.
This course is designed for primary care providers, oncologists, radiologists, surgeons, pathologists, gynecologists, and advanced practice providers who diagnose and treat patients with breast cancer.
Upon completion of this activity, participants should be able to:
- Evaluate and manage benign breast disease such as low/intermediate/high-risk lesions, and nipple discharge
- Identify patients who would benefit from genetic testing for inherited breast cancer related gene mutations
- Outline the breast health issues for transgender patients
- Illustrate surgical and reconstructive treatment options for women with breast cancer
- Explore principles of enhanced recovery and optimize the patient's surgical journey as it applies to breast cancer surgery
- Determine which patients with breast cancer merit an axillary lymph node dissection in the adjuvant and neoadjuvant setting
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this other activity (live and livestream) for a maximum of 15.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AAFP has reviewed Multidisciplinary Update in Breast Disease 2022 and deemed it acceptable for up to 15.00 Live AAFP Prescribed credits. Term of Approval is from 11/03/2022 to 11/05/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 15.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
The American Osteopathic Association designates this program for a maximum of 15.00 AOA Category 2-A credits.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
- 15.00 AAFP Prescribed
- 15.00 AMA PRA Category 1 Credit™
- 15.00 ANCC
- 15.00 AOA Category 2-A
- 15.00 Attendance